The B2C diagnostics market received a shot in the arm from the Covid-19 pandemic. As demand for PCR and LTF tests continues to subside, some are now using the extra cash earned during the last three years to invest in new consumer facing models Research included in the latest LaingBuisson report estimates the value of…
©2023 All rights reserved LaingBuisson 
 as only c£40m out of a diagnostics market worth c£8bn.){kind=link}